Clinical Trial Update: Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Pediatric Patients With Status Epilepticus (Convulsive) in the Community Setting [Phase 3]

View source ↗

Summary

Phase 3 trial data for Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in pediatric status epilepticus in community settings has been completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nervous System Diseases
• Status Epilepticus

Drugs mentioned

• Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) (Midazolam)

Snippet

Sponsor: Shire | Conditions: Nervous System Diseases | Phase 3 | Status: COMPLETED | Results posted: 2021-09-14